





The implementation of the Affordable Care Act (ACA) in 2010 made a significant impact on improving accessibility of healthcare in the U.S. The ACA requires that most individuals have health insurance. It also mandates that health insurance plans cover a minimum level of preventive services and eliminate cost-sharing to its members for these services. These mandates help to serve the overall goal of the ACA, which is to improve health. With its goals of improving health through preventive care and reducing access-related barriers, the ACA is arguably the most important piece of public health legislation in decades. The ACA contributes to public health efforts by assuring that low-income populations gain insurance coverage through Medicaid expansion and subsidies to purchase coverage through the marketplace. Lastly, the ACA contains several provisions that aim to improve quality of care, which is determined through monitoring and assessing specific disease measures of patients. 
While the ACA is clear that it seeks to improve the use of preventive services, little evidence exists on its impact on preventive care uptake. This paper evaluated preventive care use for heart disease and breast cancer, as both are leading causes of death in the U.S. Several healthcare industries affected by the ACA, specifically health plans, hospitals, and providers, were explored by discussing expectations that the ACA places on these industries to improve quality of care. Additionally, industry examples were provided to demonstrate individual efforts to improve quality. Costs were also briefly discussed since the Act suggests that improving preventive service uptake will help reduce healthcare expenditures. 
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The establishment of the Affordable Care Act (ACA) was intended to address both the poor health of the nation and rising healthcare costs. The U.S. spends more money annually, yet has worse health outcomes compared to other developed countries (Squires & Anderson, 2015). Additionally, a system lacking universal health coverage prevented people from receiving the care they needed and burdened certain industries within the healthcare field, like hospitals, with covering healthcare costs for the uninsured. 
Although the ACA did not establish a universal coverage system, it did allow for an increase in the number of insured Americans, which moves the nation closer to universal coverage. With expanded coverage, the percentage of the uninsured population has declined from 16.2% of all nonelderly adults in 2013 to 10.7% adults in 2015 (KFF, 2015b). The newly insured have also taken advantage of their coverage and reported that they were more likely to have a regular checkup or receive preventive care (47%) compared to the uninsured (27%). Additionally, the newly insured were more likely to have a doctor that they went to for regular care (44%) compared to the uninsured (25%; KFF, 2015a). 
The ACA also emphasized a need for improved access to preventive care which could potentially improve health. One way it is trying to improve access is through the elimination of cost-sharing. Before the ACA, many insurance plans required cost-sharing for preventive services. Medicare beneficiaries were required to pay 20 percent of most preventive services, while Medicare Advantage plans could require more cost-sharing from its members (Medicare Rights Center, n.d.). The ACA now requires Medicare and private insurance plans to cover the recommended preventive services at no cost to its members (Medicare Rights Center, n.d.; KFF, 2015c). 
Improving access for everyone is especially important to reduce racial/ethnic and socioeconomic disparities in preventive service use. A recent report has indicated that there is variation in preventive services based on race, education, and income. Fewer Hispanics (59.2%) noted that they have a dedicated healthcare provider compared to whites (82.1%) and African Americans (76.5%). This is especially important because access to care is strongly associated with overall preventive healthcare use. Hispanics also reported that they received fewer cholesterol and colorectal cancer screenings. Other disparities were seen in education and income. Adults that have attained a higher level of education or have a higher income are more likely to comply with recommended screening guidelines compared to adults with lower education and income levels (UnitedHealthFoundation, 2016).
With its goals of improving health through preventive care and reducing access-related barriers, the ACA is arguably the most important piece of public health legislation in decades. The goal of public health is to promote health, prevent disease, and prolong life of the whole population. The three main functions of public health include assessing and monitoring the health of populations, designing policies to address health problems, and assuring access to services that prevent disease and promote health (WHO, n.d.). The ACA fulfills all three functions of public health. One, the ACA is a national policy that will insure more individuals so they can receive necessary preventive care. Second, through Medicaid expansion and insurance marketplace subsidies, more people have affordable coverage and can access care to help them stay healthy. Lastly, the ACA includes several provisions intended to improve quality, which will be assessed by measuring certain care indicators for specific diseases.
Although the ACA seeks to improve preventive service use, not much is known about the effect of the ACA on preventive care compliance since its implementation in 2010. While its implementation began in 2010, coverage provisions did not go into effect until 2014 (KFF, n.d.). As a result of this small evaluation window, there has not been enough time to examine the full outcomes of the ACA. I will begin my analysis by reviewing the establishment of preventive care according to the ACA. Second, I will describe two areas of preventive care: breast cancer screening and heart disease prevention measures. Third, I will review the ACA’s effect on health industries as it relates to preventive services, followed by an analysis of the specified measures following the implementation of the ACA. Then I will present a brief review of costs related to preventive services. Lastly, I will provide an overall evaluation on the impact of the ACA on preventive care.
2.0 	preventive care background
This chapter will 1) describe preventive care before the ACA was enacted, 2) review specific portions of the ACA that established preventive service access and use, 3) list the healthcare industries that have been most affected by the ACA establishment, 4) define preventive care and describe breast cancer and heart disease screening, 5) briefly discuss changes that have been made to preventive care, and 6) specifically describe the ACAs influence on breast cancer and heart disease screening.
2.1	Preventive Care Pre-ACA
Preventive service use was low among Medicare-eligible patients before the ACA. The rate for preventive visits among Medicare fee-for-service patients was 1.4% (Chung et al., 2015). While this is concerning for preventive care, it is important to note that most preventive services are not necessarily provided through preventive visits. Instead, it is provided through other types of general evaluation and management visits with one’s provider. Other data suggests that before the ACA, completion of preventive visits did not correlate well with preventive service use. Less than 50% of adults 65 and older were up-to-date on preventive services even though they received preventive visits. Additionally, less than 30% of adults between the ages of 50 and 64 were up-to-date on preventive services (CDC, n.d.). 
There are numerous reasons why people choose to not use preventive care services. One barrier is cost. Thirteen percent of insured women and 9% of insured men have reported that they have not received preventive services as a result of the inability to pay. An even larger percent of uninsured women (52%) and men (42%) have listed cost as a barrier to receiving these services (KFF, 2015c). This indicates a need for increased healthcare coverage that is affordable and that also reduces or eliminates cost-sharing. Other barriers that prevent individuals from receiving preventive care include embarrassment associated with receiving the test or fear of the test itself (Klabunde et al., 2005; Vedel, Puts, Monette, Monette, & Bergma, 2011). Additionally, patients look to physicians to recommend preventive services. If physicians fail to discuss certain tests with patients, patients are less likely to receive it (Klabunde et al., 2005).
There are also physician-related barriers that affect patients. Physicians have noted that they do not have enough time with patients to discuss the needed preventive care. Additionally, they lack adequate reminder systems in which they can recognize when a patient is due for a service. Lastly, because some patients visit their physicians for acute care purposes, as opposed to preventive care, the physician may not be prompted to determine whether the patient is up-to-date on preventive tests (Guerra et al, 2007). 
2.2	Preventive Care Establishment
One goal of the ACA was to reduce the amount that the United States spends on healthcare each year by improving the health status of the population. In 2014, U.S. healthcare spending accounted for 17.5% of the nation’s Gross Domestic Product (GDP), totaling $3 trillion (CMS, 2015b). Preventive services are essential to reduce more costly care to treat injuries or illness in individuals and to improve health. For this reason, the ACA specifically addresses the need to improve access to preventive services in Title IV, “Prevention of Chronic Disease and Improving Public Health”. In general, Title IV describes the importance of promoting prevention, wellness and the health of the public. Among other provisions, this section also aims to contribute to the public health efforts by increasing funding to this important field (HHS, 2015). 
The public’s health can be improved through preventive care. Preventive care helps people to stay healthy and includes vaccinations, screening for cancers and other diseases, and education and counseling for behaviors such as alcohol misuse or tobacco use. These services are provided in order to prevent people from getting sick, or to help them detect an illness, like cancer, early when it is easiest and most effective to treat (HHS, 2016). Services to prevent both chronic and infectious diseases are delineated in Table 1, which lists preventive services for adults, women, and children. The ACA requires that these preventive services are fully covered by private health insurance and Medicare plans for certain individuals (HHS, 2015). Private insurance plans must eliminate cost-sharing (coinsurance and copays) for preventive services with the exception of health plans that have been grandfathered into the market. The ACA mandate only applies to employer-based health plans and individual health plans created after March 23, 2010. (HHS, 2015).














Table 1. Covered Preventive Services
All AdultsAbdominal aortic aneurysm screening for smokersAlcohol misuse screening and counselingAspirin useBlood pressure screeningColorectal cancer screening (50 years and older)Depression screeningType 2 diabetes screening for adults with high blood pressure	Diet counselingHIV screeningImmunizationsObesity screening and counselingSTI prevention counselingTobacco use screening and cessation interventionsSyphilis screening
WomenAnemia screening-pregnant womenBacteriuria urinary tract screening-pregnant womenBRCA testing and genetic testing at high risk for breast cancerBreast cancer mammography screening every 1 to 2 years women over 40Breast cancer chemoprevention counseling for women at higher riskBreastfeeding support and counselingCervical cancer screeningChlamydia and gonorrhea infection screening	ContraceptionDomestic violence screeningFolic acid supplement-pregnant womenGestational diabetes screening for those at high riskHepatitis B screening-pregnant womenHIV screening and counselingHPV DNA test for women 30 or olderOsteoporosis screeningRh Incompatibility screening-pregnant womenSTI counselingSyphilis screeningWell-woman visits
ChildrenAlcohol and drug use assessmentsAutism screeningBehavioral assessmentsBlood pressure screeningCervical dysplasia screeningCongenital hypothyroidism screeningDepression screeningDevelopmental screeningDyslipidemia screeningFluoride chemoprevention supplementsOral health risk assessmentPhenylketonuria screeningSTI counseling and screening	Tuberculin testingVision screeningGonorrhea eye medication-newbornsHearing screeningHeight, weight and body mass index measurementsHematocrit or hemoglobin screeningHemoglobinopathy/sickle cell screeningHIV screeningImmunizationsIron supplementsLead screeningMedical historyObesity screening and counseling
(HHS, 2015)

2.3	Industries Most Affected by the ACA
The ACA places expectations on certain members of the healthcare industry to improve preventive services. It affects health insurance plans, hospitals, the primary care workforce, employers, and health departments; however, this paper will focus on insurance plans, hospitals and the primary care workforce. Insurance plans are now required to fully cover preventive health services. Additionally, the ACA allows for Medicaid expansion in order for states to cover more individuals (HHS, 2015). States that elect to expand Medicaid will now cover adults 19 to 64 years, without children, and with an income at or below 138% of the federal poverty level (KFF, 2016). Increasing the number of insured individuals will directly increase the number of individuals who are eligible to receive preventive services. 
Hospitals are also responsible for providing preventive care. Hospitals, however, focus more directly on tertiary preventive care, which aims to slow disease progression (Academy Health, 2012). An example of tertiary care would be reducing readmissions for heart failure. Tertiary preventive care will be discussed later in this chapter. Hospitals can either be incentivized under the ACA to improve quality of care and reduce errors resulting in harm to their patients, or disincentivized for failure to accomplish these standards (HHS, 2015; Medicare.gov, n.d.a). 
Additionally, primary care providers (PCPs) play a crucial role in preventive care. PCPs are the first point of contact for a patient’s medical needs. They are also responsible for the coordination of their patients’ care. Since PCPs have direct contact with their patients, they can perform or recommend preventive services to their patients, or provide education about the importance of these services. PCPs should document whether or not their patients are up-to-date on preventive screenings. Acknowledging the importance of PCPs, the ACA incentivizes providers in the primary care field (HHS, 2015). Accountable Care Organization (ACO) models, which are groups of primary care providers, are currently being tested and evaluated by the Centers for Medicare and Medicaid Services (CMS) Innovation Center to incentivize providers to deliver better coordinated and quality care (HHS, 2015; CMS, n.d.). ACOs will be described in more detail later. Encouraging PCPs to provide better quality of care can improve their strategies to help their patients get the recommended preventive care. 
The primary care workforce has received attention because of the increase in the number of insured individuals in need of primary care. Funds, scholarships, and loan repayment programs have been created to increase the number of PCPs for underserved areas. These are part of an effort to improve access to primary care in rural areas. Funds have also been allocated to the construction and operation of community health centers, which play a crucial role in preventive care (HHS, 2015). Due to their ability to influence a patient’s uptake of preventive care, improving access to PCPs is crucial. Increasing the number of PCPs will improve their accessibility and allow for more patients to be seen by the provider in a timely manner. The expectations and influences of insurance plans, hospitals, and providers on preventive care will be discussed in chapter 3. 
2.4	Background on Preventive Care Measures
Chronic disease prevention aims to reduce the number of people suffering from conditions such as heart disease, stroke, cancer, obesity, diabetes, and arthritis. Of the health problems that people face, these are some of the most common, costly, and preventable conditions (CDC, 2015a). The four main health risk behaviors that can contribute to chronic disease include lack of physical activity, poor nutrition, use of tobacco, and excessive consumption of alcohol (CDC, 2015a). There are many preventive services that have the potential to help improve health. This paper will examine two of them, namely, preventive services for breast cancer and heart disease, and the impact the ACA has had on these two measures. Heart disease was selected because it is the number one cause of death in the U.S. for both men and women (CDC, 2015b). Therefore, the ACA has the potential to reduce a significant number of heart disease-related deaths. Breast cancer was also chosen because it is the second leading cause of death in women, and cancer as a whole is the second leading cause of death among Americans (CDC, 2015c). Additionally, there is widespread recognition of the importance of early detection of breast cancer. Although these two preventive measures are not representative of overall preventive care within the U.S., these examples can help illustrate the effects the ACA has had on preventive care uptake. Before heart disease and breast cancer are discussed in more detail, the three types of prevention will be described to provide a framework in which preventive services for heart disease and breast cancer can be placed. 
2.4.1	Types of Prevention
There are three different categories of prevention: primary, secondary, and tertiary. These three types of prevention can be used for chronic disease. Primary prevention stops the onset of disease through risk reduction (Academy Health 2012; AFMC, n.d.). It focuses on changing behaviors or removing potential exposures that could lead to disease (AFMC, n.d.). For example, consuming nutritious foods can prevent obesity in a person (Academy Health, 2012). Secondary prevention efforts detect disease when it is in an early stage and there are no signs or symptoms (Academy Health, 2012; AFMC, n.d.). A disease is usually easiest to treat in the early stage (Academy Health, 2012). Screenings performed as a secondary prevention effort are typically performed in the clinical setting or through public health programs (Academy Health, 2012; AFMC, n.d.). Tertiary prevention aims to slow a disease from progressing and causing more harm to an individual, in order to improve longevity and quality of life. In tertiary prevention, individuals already know that they have a disease, and are trying to control it through behavior or environmental modifications (Academy Health, AFMC, n.d.). For example, following a heart attack, an individual should try to reduce the reoccurrence of another cardiovascular event. He can do this by making lifestyle changes that would allow him to lose weight and thus manage his disease. (Academy Health, 2012, AFMC, n.d.)
2.4.2	Heart Disease
The leading cause of death for men and women combined is heart disease. It kills about 610,000 Americans each year. Heart disease is a general term for a range of heart conditions. Coronary artery disease is the most common type of heart disease, and refers to a decrease in blood flow to the heart, which can lead to a heart attack (CDC, 2015b). Some risk factors for heart disease include the four most common factors, plus obesity. A diet high in fat and cholesterol can lead to heart disease. Consuming too much sodium can also contribute to heart disease as it has been found to increase blood pressure. Low physical activity is another risk factor. It can even increase one’s risk of developing other conditions, which are also risk factors for heart disease. Low physical activity can lead to obesity, high cholesterol, high blood pressure, and diabetes. Additionally, consuming too much alcohol can increase one’s risk of developing heart disease because it can raise blood pressure and increase cholesterol levels. Women should consume no more than one alcoholic beverage and men should consume no more than two drinks per day to reduce his or her risk of developing heart disease. Tobacco use is also harmful for multiple reasons. The nicotine in cigarettes raises blood pressure. Smoking damages blood vessels and the heart itself, which can lead to heart conditions. Obesity can also lead to heart disease. Obesity is linked to increased blood pressure and higher cholesterol levels, which increases a person’s risk for developing the disease (CDC, 2015b).
Heart disease prevention can be evaluated based on primary, secondary, and tertiary prevention efforts. Primary prevention of heart disease includes a healthy diet and exercise in order to prevent obesity. It also includes taking a daily aspirin to prevent heart attacks. Secondary prevention includes cholesterol and blood pressure screenings (Academy Health, 2012). Tertiary preventive care may be provided after a person has been in the hospital to prevent a recurrence in cardiovascular incidents.
2.4.3	Breast Cancer
Breast cancer is the second most common type of cancer in women (CDC, 2016). In 2012, 224,147 women were diagnosed with breast cancer and 41,150 died as a result of the disease (CDC, 2014). Risk factors for breast cancer include, consuming too much alcohol, low physical activity, obesity, and excessive hormone exposure. A woman raises her risk for breast cancer by increasing her daily alcohol consumption. Women who consume two to five drinks increase their risk of developing breast cancer 1.5 times that of women who do not drink. It has also been found that women who exercise reduce their risk of breast cancer; however, it is not known how much exercise is needed to reduce one’s risk. Another factor is obesity. Obesity post-menopause raises a woman’s chance for developing breast cancer because fat cells produce estrogen. Exposure to higher levels of this hormone increases a woman’s risk of developing breast cancer. If a woman has more fat cells, more estrogen will be produced in the body, thus increasing the likelihood of her developing cancer. Other risks for breast cancer include younger age (before 12 years) of menstruation, use of oral contraceptives, and hormone therapy post-menopause, which results in exposure to hormones at higher levels or for an increased length of time. (ACS, 2016). 
Breast cancer screening can prevent breast cancer from progressing to advanced disease stages because it detects the cancer in its early stages before signs or symptoms are present. As a result, breast cancer screening is a secondary prevention tool; it screens for the presence of disease in its early stages. There are three types of screenings: clinical breast exams, a self-exam, and mammograms. Clinical breast exams are performed by a doctor or nurse in which they feel for lumps or other changes in the breast. A self-exam is similar to a clinical exam, except that the individual feels for lumps or changes in her own breasts. Mammograms are x-rays of the breast tissue. Mammograms are considered to be the best way to detect breast cancer early and will be further described in this paper (CDC, 2014).
2.5	Changes to preventive care
Mammograms and heart disease screenings, including tests for blood pressure and obesity, are now fully covered as a result of the ACA (HHS, 2015; Medicare Rights Center, n.d.). Most states also require Medicaid to cover some preventive screenings, such as mammograms (ACS, 2015). Additionally, Medicare has emphasized the need for prevention by covering annual wellness visits. Before the ACA, Medicare covered a one-time Welcome to Medicare visit that could only be used within the first 12 months of initial Medicare enrollment (Medicare Rights Center, n.d.). During these visits, providers obtained baseline measurements for patients, such as blood pressure, weight, and height. Providers also determined whether or not the patient was up-to-date on preventive services and also determined the patient’s family history and current health conditions (Medicare.gov, n.d.c). A health risk assessment could also be performed before or during visits to help physicians understand the health needs of their patients (Medicare Rights Center, n.d.). Facilitating more interactions between providers and patients has the potential to improve use of preventive services through education and provider influence.
2.6	The ACA policies regarding heart disease and breast cancer screenings
The ACA is very broad in its requirements for preventive care services. Title I and IV state that minimum preventive care is required by both Medicare, Medicaid, and private insurance plans. The preventive care to be included should have grade ‘A’ or ‘B’ recommendations by the United States Preventive Services Task Force (USPSTF; HHS, 2015). Grade A services have a substantial net benefit as documented by studies that are well-designed and representative of the targeted populations. Grade B services have a moderate to substantial net benefit. Grade B is assigned to services if research studies provide evidence of the effects of the preventive service, but are limited by such factors as the quality of the study, inconsistent findings, or lack of generalizability (USPSTF, 2013). Prevention measures for heart disease as recommended by USPSTF include blood pressure, cholesterol, and obesity screening in addition to the prescription of aspirin. Breast cancer screening includes mammograms, breast cancer preventive medications, and a BRCA risk assessment (USPSTF, 2015). Table 2 lists Grade A and B recommendations for breast cancer and heart disease preventive care in more detail.  
Although the ACA broadly identifies covered preventives services as USPSTF Grade A or B recommendations, there are parts of the ACA that specifically mention screenings for breast cancer and heart disease. Title I states that healthcare plans must use the current recommendations for breast cancer screening (HHS, 2015). Title IV addresses annual wellness visits for Medicare beneficiaries. The annual wellness visit will provide a personalized prevention plan that includes a health risk assessment, discussion of the health risk assessment, measurement of height, weight, BMI, blood pressure, and other routine measurements (HHS, 2015). Covering annual wellness visits provides Medicare beneficiaries with an extra resource to prevent or manage chronic conditions like cardiovascular disease. 
Table 2. USPSTF Recommendations for Breast Cancer and Heart Disease Preventive Care
Recommendation	Target Population	Grade
Breast Cancer		
Breast Cancer Screening every 1-2 years	Women 50-74 years	B
BRCA Risk assessment and genetic counseling	Women with a family history of breast, tubal, ovarian or peritoneal cancer	B
Breast Cancer Preventive Medications	Women at increased risk for breast cancer	B
Heart Disease		
Aspirin to prevent CVD	Men 45-79 yearsWomen 55-79	AA
Blood pressure screening	Adults 18 and older	A
Cholesterol abnormalities screening	Men 35 and olderWomen 45 and olderMen 20-35 with increased riskWomen 20-45 with increased risk	AABB
Obesity screening and counseling	All adults	B






3.0 	Industry influence on preventive care
Each healthcare industry is responsible for contributing to improved patient care and overall health. As a result, the industries must develop strategies to encourage patients to receive the necessary screenings and preventive care that will lead to successful health outcomes. This section briefly describes CMS’s role in regulating the industries and will also explain the expectations placed on each industry.
3.1	Expectations
CMS resides in the Department of Health and Human Services. While CMS is not the sole regulatory agency for managing healthcare industries, it plays a significant role in industry oversight. It administers Medicare and the federal part of Medicaid, and also sets patient health standards for providers. As a result, CMS is responsible for ensuring that its beneficiaries receive high quality services for which they are eligible (Federal Register, n.d.). These high quality services are provided by such industries as insurance plans, hospitals, and providers. CMS also houses the CMS Innovation Center, which was created by the ACA for the purpose of testing innovative payment delivery systems that will result in improved health and reduced costs (HHS, 2015). The effects of the ACA’s expectations on the industries can largely be measured by CMS’s established quality benchmarks. In this section, I will describe the quality benchmarks of the insurance, hospital, and provider industry and provide current industry practices to improve these benchmarks.
3.1.1	Insurance Plans
Healthcare plans not only cover breast cancer and heart disease screenings, but they also encourage members to receive these screenings in multiple ways, such as providing members with reminders and financial incentives to complete their screenings. These inducements by the insurance plan are done in order to improve quality of care. Insurance plans can receive bonus payments based on the quality of care they provide to their members. This is called value-based purchasing payment incentives (HHS, n.d.). Medicare Advantage Plans are evaluated based on the Medicare Star Ratings. The Star Ratings are determined by certain measures including staying healthy, managing chronic conditions, member experience, member complaints and changes in the health plan’s performance, and customer service (Medicare.gov, n.d.b). 
	Staying Healthy: The staying healthy measure assesses how well the plan does to get its members the appropriate cancer screenings, like breast cancer screening. It measures the percent of female members ages 52 to 74 years who received a mammogram in the last two years. Additionally, it measures the percent of the plan’s members who talked to their doctors about exercising, in order to monitor physical activity. It also measures the percent of members who were checked to determine if they were at a healthy weight by measuring patient BMI (Medicare.gov, n.d.b). Table 3 provides the measure’s percent benchmarks that determine the number of stars given to each plan based on member completion of the measure.
	Managing Chronic Conditions: Managing chronic conditions is also essential to preventive care. A measure for health plans in this category includes controlling high blood pressure. This is measured by the percent of members who have high blood pressure but received treatment and were able to maintain a healthy blood pressure (Medicare.gov, n.d.b). The benchmarks for this measure are seen in Table 3.

Table 3. 2015 Medicare Star Rating Benchmarks for Staying Health and Managing Chronic Conditions Measures





Controlling High Blood Pressure	<42%	42%	53%	63%	75%




	The ACA also mandates the measurement of quality of qualified health plans on insurance marketplaces, called the Quality Rating System (QRS). QRS consists of a rating that combines measure data and survey responses to create a quality performance rating, similar to the Medicare Star Rating, on a scale of 1 to 5. This rating, which is available on the marketplace, reflects the quality of healthcare services and health outcomes, consumer experience, and access to care provided by the plan (Health Insurance Marketplace, 2014). Benchmarks for the specified measures could not be found.
	QRS Clinical Measure: The QRS clinical measures for breast cancer screening and heart disease screening use the Healthcare Effectiveness Data and Information Set (HEDIS) measures developed by the National Committee for Quality Assurance. One measure includes controlling high blood pressure. This measures the percent of members 18 to 85, with a hypertension diagnosis, that had their blood pressure under control. Another heart disease measure is adult BMI assessment. The BMI assessment is determined by the percent of members 18 to 74 whose BMI was documented by a provider. This ensures that providers are tracking the weight of their patients. Reaching a specific BMI target is not required for this measure. Lastly, mammograms are measured by the percent of female members 50 to 74 who received a mammogram (Health Insurance Marketplace, 2014). 
	QRS Survey Measure: A QRS survey measure includes aspirin use. The measure is determined by the percent of members who are currently taking aspirin. Those eligible for this measure include women 56 to 79 years with two or more risk factors for cardiovascular disease (CVD), men 46 to 65 years with one or more risk factors, and men 66 to 79 years regardless of their risk for CVD (Health Insurance Marketplace, 2014).
	The insurance industry has developed new ways to improve preventive service use by its members. It is important to acknowledge that many new programs have been implemented, but have not yet been evaluated because evidence on its effectiveness is just starting to emerge. Medicaid managed care organizations (MCOs) are enhancing care by improving coordination, access and delivery of care, strengthening the community infrastructure, and reducing disparities (Silow-Carroll & Rodin, 2013). Multiple strategies were developed to advance these initiatives. One plan worked with community partners to provide counseling on such topics as blood pressure screenings, breast cancer screenings, diet, exercise, and chronic diseases to its members (Silow-Carroll & Rodin, 2013). Working with these partners and members of the community is crucial in order to improve health in the long run. Another strategy employed by an MCO placed clinical teams in various locations, such as nursing homes and adult day care centers, where many of its members are located to provide them with coordinated primary care (Silow-Carroll & Rodin, 2013). Strategies may also include incentives for both providers and members to encourage preventive care and healthy living. Another method that one of the plans uses is a special system that alerts care managers and member services of any care gaps the patient may have. This is done so that the patient can be reminded, educated, or scheduled for preventive services that they have not yet completed, such as mammograms (Silow-Carroll & Rodin, 2013).
Private insurance plans are also encouraged to work with Medicare and other public programs in the Comprehensive Primary Care Initiative. Through this initiative, insurers are encouraged to ensure that providers have the resources they need to improve delivery of care to its patients with the highest healthcare demand. An initiative between the plan and provider allowed for the development of a close partnership in which the insurer gave the provider access to their claims database. As a result, the providers were able to better target groups of patients with specific illnesses (Hostetter & Klein, n.d.).
3.1.2	Hospitals
Although hospitals are often thought to only treat the sick, they can play a vital role in tertiary preventive care. Hospitals contribute to care among their patients suffering from heart disease or other illnesses. Added pressure to improve care and health event outcomes by hospitals is described in the ACA. Medicare incentivizes hospitals to improve their quality of care through several mechanisms, one of which is a value-based purchasing program. The value-based purchasing program provides incentive payments to high performing hospitals while penalties are issued to poor performers. The initial measures included in this incentive program focus on high-cost conditions such as heart attacks, heart failure, pneumonia, surgical care, healthcare-associated infections and the patients’ perception of care. Medicare may reduce payments to acute care hospitals for an excessive number of patients with these conditions who return to the hospital for care (HHS, 2015). Readmission rates are compared to a national average. If hospitals are below the average, they are doing well in terms of readmissions. If hospitals are above the national average, they are performing poorly (Medicare.gov, n.d.a). As a result, hospitals must improve patient care while the patient is in the hospital and after he is discharged, in order to prevent readmission. Readmissions could be caused by complications from treatment, treatment that is inadequate, poor care coordination and an unexpected worsening of the condition post-discharge (Medicare.gov, n.d.a). The ACA acknowledges that transitioning from a hospital to another facility can be a barrier to appropriate care and thus created the Community-Based Care Transitions Program in which the program goals are to reduce hospital readmissions, maintain or improve quality of care, test effective and sustainable funding streams for transitions of care services, as well as reduce costs for Medicare (Stamp, Machado & Allen, 2014). Additionally, to further encourage improvement in quality of care, hospitals must publicly report their performance (HHS, 2015). Hospital ratings can be found through Hospital Compare on the CMS website. 
In order to prevent readmissions, hospitals need to improve their quality of care. Readmission rates refer to any potentially preventable readmission within 30 days of discharge (Silow-Carroll, Edwards & Lashbrook , 2011). There are a range of evidence-based practices that have been shown to successfully reduce readmission rates. For example, some of the top-performing hospitals have drastically reduced readmissions for patients with heart attack, heart failure, and pneumonia by focusing on transitions of care (Silow-Carroll et al., 2011). Transitions of care require the coordination of care for patients when they are transferred from one location to another (Stamp et al., 2014). There are several different approaches to transitions of care models. One such approach involves a partnership between the hospital and a home health agency. The home health agency is responsible for providing post-discharge care for all of the hospital’s patients (Silow-Carroll et al., 2011). Other successful strategies involve a 72 hour or 7 day post-discharge follow-up by a case manager. The case manager reinforces education, ensures the patient has followed-up with his PCP, and may even perform home visits (Schell, 2014; Silow-Carroll et al., 2011; Stamp et al., 2014). A similar strategy uses a case manager to monitor blood pressure, pulse, oxygen saturation, blood sugar, and weight through a telemonitoring device given to cardiac patients at discharge. The case manager regularly checks those measurements and provides a follow-up call with the patient if abnormal results are observed. This method has the potential to contribute to a reduction in readmission rates by as much as 47% (Silow-Carroll et al., 2011). 
Other successful evidence-based strategies involve inpatient education and counseling by a nurse. The teach-back method has been proven to be effective in properly educating patients. This method requires patients to explain the post-discharge instructions to the nurse. Daily repetition of information has also been proven to be effective (Schell, 2014; Silow-Carroll et al, 2011; Stamp et al, 2014). Other evidence suggests providing patients with post-discharge resources. For example, patients who cannot afford their medication are provided with information on medication assistance programs and free medication clinics to ensure patients adhere to post-discharge instructions (Silow-Carroll et al, 2011). 
3.1.3	Primary Care Providers
The ACA expects certain qualities from PCPs. These qualities are so important that the ACA allows for grants to be awarded to institutions, such as medical schools and physician assistant training programs, to teach PCPs how to provide well-coordinated patient care. Some of the qualities that are encouraged in these training programs include collaboration among healthcare professionals, preventive care, and improved communication with patients (HHS, 2015). These specified qualities indicate the vital role PCPs play in communicating with patients to provide education about preventive care. Additionally, the provider monitors specific indicators of his patient’s blood pressure, cholesterol, and BMI to determine the risk for heart disease or other conditions. Lastly, PCPs coordinate patient care by ensuring that their patients are up-to-date on screenings or receive other necessary care to treat conditions.
In order to help patients find primary care providers that provide quality care, the ACA requires that Physician Compare, found on the CMS website, provides information on physician performance. It is based on measures for quality and patient experience (CMS, 2014a). The measures address prevention, chronic and acute care management, procedure-related care, resource utilization, and care coordination. To encourage physicians to report the measures, CMS has implemented a negative payment adjustment for eligible professionals and group practices, in which physicians could receive reduced payments for their services if they do not report certain measures (CMS, 2015a). This will not only provide a resource for patients to find physicians who provide excellent quality care, but it will also incentivize providers to provide better preventive and disease management care.
The ACA is also trying to bolster the primary care workforce and improve quality of care for this healthcare industry through ACOs. Physicians are encouraged to form ACOs with financial incentives. If physicians meet specific quality benchmarks in their patient population, in addition to reducing the cost to care for their patients, the physician can receive a payment from a portion of those healthcare savings (Abrams et al., 2015; HHS, 2015). In order to be eligible to form an ACO, the organization must consist of at least 5,000 Medicare fee-for-service beneficiaries. The ACOs must also perform routine monitoring and self-assessments, which will be reported to CMS (CMS, 2014b).  The goal of the ACO model is to improve the quality of care, prevent illness, and decrease the number of unnecessary hospital admissions through better coordination of patient care (HHS, 2015). Quality of care is measured through specific benchmarks. Measures related to heart health include blood pressure screening in adults in the past two years and the percent of patients with hypertension with a blood pressure that is less than 140/90. Breast cancer screening is not listed as a measure for ACOs. Additionally, an ACO measure includes hospital readmissions (Abrams et al., 2015). This places expectations on providers to coordinate care for patients with such conditions as heart disease, after they have been discharged from the hospital. Minimum and maximum benchmarks for these measures are based on performance of all non-ACO Medicare providers (Abrams et al., 2015). Specific benchmark values could not be found. Since an ACO’s primary focus is to manage patients with high needs, preventive service use will be more focused on tertiary preventive care through monitoring and controlling the patient’s condition. This will better allow physicians to ensure their patients receive appropriate care to prevent adverse health events, such as a heart attack. 
The establishment of ACOs has encouraged providers to develop new strategies for addressing patients with high needs. Evidence suggests that there are better patient health outcomes when providers focus more of their resources on patients with high needs, such as diabetes. Such outcomes may be achieved through longer patient-provider interactions (Hostetter & Klein, n.d.). Practices that partner with entities outside of the practice may benefit as well. In order to control a patient’s medical condition, clinics may partner with social workers and health coaches to explain medication and healthy habits. Health coaches can be used to keep in daily contact with patients (Hostetter & Klein, n.d.). Using additional resources from the community allows the patient to receive more care related to their disease, without taking up more of a physician’s time, which is in high demand. 
Other evidence suggests that ACOs improve performance when they invest in data analytics tools, information technology systems, and staff, all of which could be used to better identify at-risk patients and continuously monitor their care. Patients seeing providers in ACOs found that they had more timely access to care and that their providers were better informed about any needed specialty care. Patients who had multiple chronic conditions rated their quality of care with the ACO model higher compared to a regular provider practice model (Hostetter & Klein, n.d.).
4.0 	Post-ACA Rates
Since the ACA aims to reduce financial barriers to receiving preventive care, one would expect an increase in service use following its implementation. A literature review of mammography uptake as well as prevention measures for heart disease was performed to determine whether changes in service rates occurred following the implementation of the Act.
4.1	Breast Cancer Screening
Recent research has found varying results for mammography uptake following implementation of the ACA. A study completed between 2009 and 2012 that sampled 5% of Medicare claims found an increase in mammography post-ACA. The study also found that variables associated with an increase in mammography use included younger age, lower comorbidity, receipt of a previous mammogram, and preventive health visits (Cooper, Kou, Schluchter, Dor & Koroukian, 2016). 
Other evidence suggests an increase in mammography uptake may be linked to expanded insurance coverage. One study examined mammography uptake in a large health system. Uptake rates were examined in three age groups based on USPSTF guidelines (40-49, 50-74, and 75 and older). USPSTF guidelines recommend that women 40 to 49 years be selectively screened based on individual risks and women 50 to 74 receive mammograms every 2 years. It also recommends that women 75 and older forego mammograms as there is not strong evidence that this age group benefits from mammograms. The sample evaluated in this study included women with commercial insurance, Medicare, and Medicaid. The authors found that there was an increase in screening volume for those within the recommended guidelines (50 to 74), but a decline in all other age groups (Nelson, Weerasinghe, Wang & Grunkemeier, 2015). This makes sense given that women younger or older than the 50 to74 year age group would no longer be expected to receive mammograms. The findings that mammography uptake increased in 50 to 74 year olds suggests that expanded insurance coverage may improve access to preventive care. 
Although there is some evidence for improved mammography uptake after the implementation of the ACA, there is contradicting evidence that suggests mammography rates have not changed. One study compared 2008 and 2013 mammography rates from the National Health Interview Survey for women with private insurance or Medicare. Mammography rates had minimal change, staying around 70.2% for each study year. This study also examined colorectal cancer screening rates which had a different outcome. Colorectal cancer rates increased after implementation of the Act. The authors state that this difference in results could be the result of cheaper mammograms compared to colorectal cancer screening before the ACA (Fedewa et al, 2015). Therefore, the lower cost of mammograms enabled more women to receive mammograms, while the higher cost of colonoscopies was a barrier that prevented individuals from receiving this screening pre-ACA. Additionally, the ongoing focus on breast cancer awareness initiatives may have kept mammography rates steady (Fedewa et al., 2015).
Other evidence also supports that mammography rates have not changed post-ACA. A study using data from the Medical Expenditure Panel Survey (MEPS) assessed preventive services from three groups: privately insured 18 to 64 years, Medicare beneficiaries 65 and older, and the uninsured 18 to 64 years. The study found that there was no change in mammogram uptake, except for an increase in mammography completion for women without a chronic condition. As a result, other barriers to mammography uptake may be present for women who have chronic conditions (Han, Yabroff, Guy, Zheng & Jemal, 2015).
Results from a private plan-only analysis also indicated that there has not been much improvement in mammography rates. Mammography claims were used to detect uptake in women 50 to 64 years enrolled in a small-business health plan. The authors cite that rates may not have changed because women do not know that the ACA eliminated cost-sharing for mammograms (Mehta et al, 2015). Poll data on knowledge of the changes to cost-sharing confirms this statement. In March 2014, only 43% of the population reported that they were aware of the elimination of cost-sharing for preventive services (KFF, 2015c).
Additionally, mammography uptake has not improved for Medicare or Medicaid beneficiaries. Before the ACA, Medicare beneficiaries could purchase supplemental insurance, which covered copays or coinsurance for preventive services. Those with traditional Medicare, in which beneficiaries were responsible for all out-of-pocket expenses, had lower rates of preventive care services. One would assume that the removal of cost-sharing would improve rates of mammography for the traditional Medicare group. However, this did not occur as mammography rates stayed the same (Jensen, Salloum, Hu, Ferdows & Tarraf, 2015). Medicaid beneficiaries did not fare any better. A 2014 report on Medicaid beneficiaries that examined HEDIS 2011-2013 data found no significant change in breast cancer screening rates (HHS, 2014). These results reinforce the idea that cost is not the only barrier to receipt of preventive services. 
While some evidence suggest mammography rates have stayed the same or increased after ACA implementation, other evidence indicates a decline in mammography completion rates. Using registry-based data in Vermont, a study found that only 45.3% of women 40 years and older in 2009 received a mammogram, but in 2011, rates dropped to 41.6%. The study also found that the greatest decline was for women between 40 and 49. The decrease correlates with the change in USPSTF mammogram guidelines in which women receive selective screenings based on their risk for breast cancer. The study also noted, however, that there was still a decline in mammography uptake for women 50 to 74 years, who are recommended to receive mammograms (Sprague et al, 2014).
In summary, numerous studies have found mixed reviews of the ACA’s effect on mammography uptake. Some studies indicate an increase in uptake following the elimination of cost-sharing. However, results have not been consistently demonstrated across the nation or within certain populations. There is evidence that suggests women with chronic diseases may be less influenced to receive screening. Additionally, mammography rates in one state’s Medicaid population was found to have declined. Lastly, increased insurance coverage may result in more women who can now afford mammograms, but there is currently limited evidence of its effect on mammography uptake. Therefore, based on these varying results, it is difficult to determine the ACA’s overall effect on mammography uptake.
4.2	Heart Disease Screening
Effects of the ACA on preventive care for heart disease have not been studied as thoroughly as breast cancer screenings. Evaluation of MEPS data between 2009 and 2012 found that the greatest amount of change occurred in 18 to 64 year olds with private-insurance for blood pressure (prevalence ratio (PR)=1.03) and cholesterol screening (PR=1.13), but only cholesterol testing (PR=1.06) increased for those on Medicare 65 and older (Han et al., 2015).
Medicaid beneficiaries also did not see improvements in the management of heart disease. There was no significant change in the HEDIS measure for controlling high blood pressure, which stayed around 56%. Not only was there not much improvement for this measure, but most of the clinical measures, such as cervical cancer screening and LDL-C screening for diabetics, did not demonstrate significant changes. There was a significant increase in completion of a BMI assessment of 24.4%. However, this is most likely due to a change in data collection during the time period in which the measure went from administrative (claims) to hybrid (claims plus medical record review) data collection procedures (HHS, 2014).
Another study indirectly indicated an increase in heart disease preventive screenings based on coverage. The study assessed insurance coverage and the probability of diagnosis for chronic conditions such as hypercholesterolemia and hypertension. Data were evaluated between 1999 and 2012 from the National Health and Nutrition Examination Survey. Evidence suggests that those who have insurance are more likely to be diagnosed with hypercholesterolemia or hypertension than those who do not have health insurance. Additionally, the study found that those who are insured and already have a chronic condition have significantly lower total cholesterol and systolic blood pressure than the uninsured. This indicates that cost as a barrier to managing chronic conditions may be reduced (Hogan et al., 2015).
	Other evidence evaluated ACOs and their effectiveness in meeting quality benchmarks. Only 39% of the ACOs were able to meet the maximum quality benchmark for blood pressure screening in the past 2 years, but 56% did meet the minimum quality standard. Only 5% of ACOs met the maximum quality standard for the percent of patients with blood pressure less than 140/90 while 80% met the minimum benchmark (Abrams et al., 2015). While over half of the ACOs were able to meet minimum quality benchmarks for both blood pressure screening and blood pressure control, they must improve to be more effective and meet the maximum benchmarks.
5.0 	Costs
In addition to making Americans healthier, the ACA aims to reduce healthcare spending. Healthcare expenditures currently account for roughly 25 to 30% of the federal budget (Cauchi, Hinkley & Yondorf, 2015). The ACA is expected to save federal and state governments money through their respective Medicare and Medicaid operations. One source estimates preventive care could potentially save the U.S. over $16 billion dollars each year within five years by preventing or delaying chronic diseases. Treatment for heart disease, cancer, arthritis, and diabetes currently accounts for over 75% of health care costs. (Cauchi, Hinkley & Yondorf, 2012). 
Although contradictory to the belief that the ACA will save money on healthcare spending through clinical preventive care, strong evidence suggests that it is unlikely that these services will reduce costs. Some preventive care interventions will improve health and reduce costs, such as childhood immunizations or educating on the use of low-dose aspirin, but most improve health while increasing the cost of care, such as screenings. Additionally, prevention allows for people to live longer and thus, they may die of other diseases that also cost money (Academy Health, 2012; The Advisory Board Company, 2015; Cohen & Neumann, 2009). 
Preventive care not only can be evaluated based on cost-savings, but also on cost-effectiveness. Preventive care is considered to be cost-effective if its benefits, such as quality adjusted life years (QALYs), are relatively large compared to its costs. While a cost-effective service may not save money, the added expense of that service may be justified if the resulting health benefits gained are large (Cohen & Neumann, 2009). 
Due to the difficulty in determining costs and cost-savings of preventive care, it may be better to evaluate preventive care based on overall value (Cohen & Neumann, 2009; The Advisory Board Company, 2015). The ACA’s expectation that preventive service coverage will reduce healthcare costs is not only unlikely, but it also underscores the need to evaluate preventive care based on QALYs and disability adjusted life years (DALYs). QALYs are a standard measure to determine the impact of a health-related event, such as breast cancer, on quality and length of life. QALYs are determined by weighting length of life by the quality of life (QALYs=length x quality). This measure essentially determines how much life is achieved due to an intervention. As a result, numerous interventions can be evaluated and compared using QALYs. DALYs quantify the burden of disease and are calculated by determining a set burden rate and multiplying it by the number of people affected by the disease. DALYs determine the health gap, in which a person’s life with the disease burden is subtracted from the person’s length of life when they are in good health. QALYs are more often used in the U.S., where chronic diseases persist and a focus on measuring value of care is prevalent (NRC, 2010). 
Modeling data has found that women 50 to 74 years of age who received a mammogram biennially gained a median of 86 QALYs per 1,000 women compared to women who were not screened (Mandelblatt et al., 2016). QALYs for heart disease preventive care could not be found in a literature search. At this time, using QALYs and DALYs to determine health outcomes from preventive service use cannot be evaluated. In the future, QALYs and DALYs may be a better way to measure these outcomes. The rest of this section will briefly touch on cost and cost-effectiveness of breast cancer and heart disease prevention, however, a full economic evaluation of these services is beyond the scope of this paper.
5.1	Breast Cancer
Overall, breast cancer screening and treatment costs since the ACA enactment are difficult to find. In 2010, $16.5 billion were spent on direct costs of breast cancer treatment (NCQA, n.d.). Coverage status is important to improve outcomes and reduce individual spending. Uninsured women are 2.9 times more likely than insured women to be diagnosed in the later stages (III and IV) of breast cancer (Rice, Rosenau, Unruh & Barnes, 2013). As a result, more costly care is needed to treat those women with breast cancer detected in the later stages. With each increase in stage of breast cancer, cost increases by about $20,000 to $25,000 per stage (Farley et al, 2015).
In an analysis of several studies evaluating cost-effectiveness of mammograms, the cost-effectiveness ranged from $31,000 to $101,000 per life year. This is considered to be cost-effective as the threshold is typically $50,000 to $100,000 per QALY (Cohen & Neumann, 2009). Mammograms are less cost-effective the more often it is performed. Although increasing frequency of screenings could have the potential to detect breast cancer sooner and thus increasing effectiveness, it is not cost-effective for any age group. Annual screenings have the highest cost per life saved (Gocqun, 2015; Cohen & Neumann, 2009). This may be due to increased false-positives associated with increased mammogram frequency. The average cost for a false-positive mammogram is $852, while a false-positive for invasive breast cancer is significantly higher at $51,837. Overall, breast cancer false positives cost the nation about $4 billion each year (Ong & Mandl, 2015). 
Other important issues must be addressed to reduce cost and improve health outcomes. African American women and women with low socioeconomic status typically have poorer breast cancer outcomes and are more likely to die from it. In one study evaluating this group of women, about half were diagnosed after symptoms appeared rather than through routine screening. Most of these women had no prior mammogram (Farley et al., 2015). Since the breast cancer was not detected by a screening mammogram, these women are at an increased risk for being diagnosed at a more advanced and costly stage. This finding identifies disparities in preventive care that need to be addressed.
5.2	Heart Disease
Heart disease prevention costs were also difficult to determine. In 2010, CVD cost the U.S. about $450 billion in both direct and indirect costs (NCQA, n.d.). At the state level, the median state medical costs of CVD are close to $4.3 million (Trogdon et al, 2015). Medical costs due to high blood pressure amount to over $46 billion per year. (NCQA, n.d.). 
Blood pressure screening was found to be both cost-saving and cost-effective. Cost-effectiveness for this measure ranges from $29,000 to $38,000 per QALY. Additionally, cost-effectiveness for cholesterol screening and provision of medication where appropriate is slightly higher at $46,000 per QALY. Adult obesity screening and follow-up with counseling, medications, or surgery can be relatively cost-effective ($42,000 per QALY) or not cost-effective at all ($200,000 per QALY; Cohen & Neumann, 2009). 
As a primary prevention strategy, aspirin use may be a cost-effective option for preventing heart attacks and strokes, but there is little cost-effectiveness data for CVD primary prevention in general. One specific intervention in Minnesota evaluated the cost-effectiveness of implementing a statewide campaign to promote aspirin use versus the costs when no campaign was implemented. The study found that the lifetime benefits for improving quality of life and reducing heart attacks and strokes were greater than the costs associated with using aspirin (Michaud et al, 2015). Other studies identify counseling on aspirin use as generally cost-saving (Cohen & Neumann, 2009).
Transitions of care may be a cost-effective option in reducing hospital readmissions for chronic heart disease, however, more research needs to be done. One transitions of care model involved a tailored health plan developed by a nurse. Overall, there were no significant changes in costs or QALYs as a result of this intervention. However, the study showed that the intervention reduced the risk for readmission only in men and not women (Byrnes et al, 2015). As a result, current practices to reduce admissions in the healthcare industry may need to be customized depending on the population (ie. male vs. female) to be the most cost-effective. Another study found varying cost outcomes for transitions of care interventions. Some showed a reduction in costs while others did not. The programs that were most effective at reducing costs included home visits to the patient by a healthcare professional with or without a follow-up telephone call (Stamp et al, 2014).
6.0 	Evaluation
Improving preventive care use across the nation will take time before the value of the ACA can be fully understood. Currently, there is not enough data to fully evaluate the impact that the ACA has had on preventive care rates and the health of the public. However, based on limited evidence, there have been some increases in uptake of mammography and heart disease screening and management in the U.S., but consistent results have not been observed. It is acknowledged that the elimination of cost-sharing reduces a barrier to preventive care and improves access. Additionally, an increase in healthcare coverage could increase the number of people who get screened.
Evaluating changes in screening rates is difficult due to inconsistent data collection. For instance, data collected for breast cancer screening rates sometimes include women outside of the current recommended guidelines. Additionally, with the change in guidelines, it is difficult to compare pre- and post-ACA implementation rates. Some of the declines in mammography uptake could be attributed to low-risk women 40 to 49 years who are no longer expected to get a mammogram. Future measurements of mammography rates will need to focus on women between 50 and 74 years who are consistently expected to get a mammogram. Other issues arise with data collection. As a result of HEDIS changing their data collection strategies from administrative to hybrid, the recorded number of people who had a BMI assessment significantly increased. Issues like these prevent a full understanding of the scope of preventive care completion across the nation and within subgroups of the population. 
An issue to consider in evaluating the impact of the ACA on preventive care is that elimination of cost-sharing is not the only factor that prevents people from receiving appropriate care. People do not receive preventive care for many reasons, one of which is the fact that many individuals are not aware of the change in benefits, which eliminated cost-sharing. Other barriers exist in which some people may not use preventive care because their attention is on other health conditions or they do not perceive themselves to need this care. They may also have transportation issues or other obligations. While broad policy interventions may help alleviate some of these barriers, the nation needs to move past generalizable interventions. Instead, it would be beneficial to provide more tailored interventions to specific subgroups within the population. In return, these tailored interventions could help reduce disparities in preventive care.
This is where healthcare industries can make a bigger impact. The federal government has set quality standards for insurance plans, hospitals, and providers to support improvements in overall care. However, the government does not specify the type of intervention or elements to be implemented within each industry to improve these measures. Insurance companies encourage providers to educate, perform and/or recommend preventive care and healthy living through incentives. Plans may also work with community partners to target specific populations and improve health within the community. In order to increase uptake of preventive services, these industries will need to identify and maintain effective programs and develop innovative strategies to ensure its patients can access and receive appropriate care.
With the threat of monetary penalties for too many readmissions, hospitals are faced with improving their quality to ensure that its patients receive excellent tertiary preventive care both inside and outside of the hospital. Transitions of care models appear to be valuable tools in reducing readmissions, but hospitals need to be mindful about the patient’s home life and factors that could prevent patients from managing their conditions. Additionally, hospital workers should be monitoring patients who are readmitted to hospitals and determine how they can improve readmission rates. They must be mindful of the fact that a single intervention will not make the same impact for each patient.
Providers can make a significant contribution to preventive care. Although new payment systems, like the ACO, are still being tested, it appears that it has the potential to better manage high needs patients and improve health. Most ACOs have been able to meet at least the minimum benchmark for certain heart disease measures, but many still need to make improvements to reach the maximum quality benchmarks. It is also difficult to assess ACOs because there is no precedent in which comparisons can be made. The question remains as to whether or not ACOs can be a sustainable solution as some ACOs had to drop out of the pilot program for financial reasons.
While the ACA seeks to improve costs through payment reform and preventive service coverage, evaluating preventive care outcomes based on cost does not appear to be the best option. Preventive care, like mammograms and heart disease screening and management, can be an effective way to reduce diseases and its associated costs; however, in general, this type of care is not usually cost-saving. Current healthcare spending patterns do not indicate cost savings, but there are many factors that contribute to this, such as the increase in number of insured people and improvements in technology. Even though the ACA seeks to reduce healthcare costs, it is not a good outcome measure to determine the effectiveness of preventive care use and improvements in health. Rather, measurements like QALYs or DALYs are a better alternative.
This paper sought to evaluate the ACA’s impact on preventive care uptake specifically looking at breast cancer screening and heart disease screening and management. However, based on the findings, there is insufficient evidence to determine the overall effects of the ACA on these preventive services. Instead, it reinforces the need for each healthcare industry to improve access and quality of care to reduce disease and improve health in local communities. Additionally, the U.S. should not use cost to measure the success of preventive care, but rather find a better way to collect data and measure outcomes related to health. Overall, the ACA has the potential to be an effective policy to improve quality and increase use of preventive care. However, further data collection and evaluation of these services is needed before a final decision on ACA effectiveness can be made.
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